Fingerprint
Dive into the research topics of 'NurOwn, phase 2, randomized, clinical trial in patients with ALS: Safety, clinical, and biomarker results'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
NurOwn, phase 2, randomized, clinical trial in patients with ALS: Safety, clinical, and biomarker results
James D. Berry, Merit E. Cudkowicz, Anthony J. Windebank, Nathan P. Staff, Margaret Owegi, Katherine Nicholson, Diane McKenna-Yasek, Yossef S. Levy, Natalie Abramov, Haggai Kaspi, Munish Mehra, Revital Aricha, Yael Gothelf, Robert H. Brown
Research output: Contribution to journal › Article › peer-review
20
Scopus
citations